MHC
MDCX

May Hill Capital’s Medicus Pharma MDCX Stock Holding History

May Hill Capital’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6K Hold
50,622
– – ﹤0.01% 256
2026
Q1 		$23.2K Buy
50,622
+15,000
+42% +$15.7K 0.01% 223
2025
Q4 		$54.5K Buy
35,622
+17,811
+100% +$38.2K 0.01% 199
2025
Q3 		$41.2K Sell
17,811
-17,811
-50% -$44.7K 0.01% 189
2025
Q2 		$107K Buy
+35,622
New +$142K 0.04% 186

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

May Hill Capital's MDCX Position: Q2 2026 in Review

May Hill Capital held its Medicus Pharma (MDCX) position steady in Q2 2026 at 50,622 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #256.

May Hill Capital first reported a position in MDCX in Q2 2025 and has held it in 5 quarters since. The position peaked at $107K in Q2 2025. 23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • May Hill Capital held 50,622 shares of Medicus Pharma worth $22.6K as of Q2 2026.
  • May Hill Capital left its Medicus Pharma share count unchanged in Q2 2026.
  • Medicus Pharma made up ﹤0.01% of May Hill Capital's portfolio in Q2 2026, its #256 holding.
  • May Hill Capital first reported a position in Medicus Pharma in Q2 2025 and has held it in 5 quarters since.
  • May Hill Capital's Medicus Pharma position peaked at $107K in Q2 2025.
  • 23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on May Hill Capital's 13F filing for Q2 2026, filed 7 Aug 2026.